Digital Look

Welcome to Digital Look++,
you are not logged in

Oxford Biodynamics (OBD)

113.50p

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Sep-15	0.70	(1.37)	(1.30)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-16	1.09	(2.07)	(2.10)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-17	1.18	(4.03)	(4.50)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-18	1.19	(2.42)	(2.20)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-19	0.91	(3.39)	(3.00)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Sep-20	2.12	(2.77)	(2.50)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-21	5.79	0.58	0.50p	227.0	n/a	n/a	n/a	0.0%

EpiSwitch used in diagnosis of canine lymphoma	15-Jan-2020	14:15	RNS
OBD enters into master service agreement	20-Dec-2019	07:00	RNS
PDMR Shareholding	11-Dec-2019	11:00	RNS

Director dealings: Oxford Biodynamics interim ch...	11-Dec-2019	ShareCast
Three AIM firms celebrate Queen's Award for Ente...	23-Apr-2019	ShareCast
Oxford BioDynamics biomarker to be used in prost...	19-Mar-2019	ShareCast

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.